A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea.

Br J Cancer · 2013 · PMC3619064 · PMID 23462724

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Data from the acute phase suggest use of AGI004 doubled the odds of response relative to placebo (OR=2.0, 90% CI: 0.9–4.5); however, again this did not reach statistical significance ( Table 2a ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.